Halozyme Therapeutics is a biopharmaceutical company based in San Diego, California, that develops enzyme-based products for drug delivery. Its main technology, ENHANZE, uses a recombinant human hyaluronidase enzyme to help other medicines be given as subcutaneous injections rather than intravenous infusions. The company licenses this technology to pharmaceutical partners and also markets its own enzyme products and drug-delivery devices. Its customers are mainly drug developers and healthcare providers.
The shares are listed on the London Exchange in UK under the code 0J2O, and the price on this page is in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #273 of 3787 on the London Exchange · confidence Medium
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendStrong
98/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average52.9%
From 52-week high0.0%
MomentumStrong
98/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return56.6%
6-month return86.7%
Stability (higher is calmer)Fair
53/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)38.9%
Worst drawdown, 1 year (smaller is calmer)-24.0%
LiquidityWeak
33/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.14M USD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 59.85 – 127.76Daily closes, split-adjusted
Signals
50-day average111.21
200-day average82.02
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)4.29
Technical summary
Daily
Bullish
11 bullish · 0 neutral · 4 bearish
Weekly
Strongly bullish
6 bullish · 0 neutral · 1 bearish
Monthly
Strongly bullish
1 bullish · 0 neutral · 0 bearish
Moving averages (daily)
SMA 10
120.1
Bullish
EMA 10
120.8
Bullish
SMA 20
115.3
Bullish
EMA 20
117.2
Bullish
SMA 50
111.2
Bullish
EMA 50
109.5
Bullish
SMA 100
95.07
Bullish
EMA 100
99.22
Bullish
SMA 200
82.02
Bullish
EMA 200
–
n/a
Oscillators (daily)
RSI (14)
71.43
Bearish
MACD (12, 26)
4.33
Bullish
Momentum (12)
11.95
Bullish
Stochastic %K (14)
88.48
Bearish
Williams %R (14)
-11.52
Bearish
CCI (20)
122.2
Bearish
Pivot points (classic, last session)
S3
117.7
S2
120.2
S1
122.8
Pivot
125.3
R1
127.9
R2
130.4
R3
133.0
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in USD. Educational only, not financial advice.
